Edesa Biotech, Inc.
EDSA
$7.69
$0.699.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.25M | -2.23M | -1.75M | -1.59M | -1.62M |
| Total Depreciation and Amortization | 25.50K | 25.90K | 25.80K | 24.50K | 43.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 399.90K | 404.40K | 177.40K | 66.70K | 81.20K |
| Change in Net Operating Assets | -265.00K | 77.10K | -154.50K | -884.00K | -24.20K |
| Cash from Operations | -2.09M | -1.72M | -1.70M | -2.38M | -1.52M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.50M | 220.50K | 0.00 | 6.87M | 626.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 8.34M | 1.54M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -142.40K | -34.00K | 0.00 | -437.50K | -96.00K |
| Cash from Financing | 3.36M | 186.50K | 0.00 | 14.77M | 2.07M |
| Foreign Exchange rate Adjustments | -8.50K | -35.00K | 165.80K | -56.40K | -28.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.26M | -1.57M | -1.54M | 12.33M | 526.20K |